Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will
report financial results for the fourth quarter and full year 2013 on
Thursday, March 6, 2014, after market close.
Company management will host a conference call at 5:00 pm Eastern on
March 6, 2014 to discuss the financial results for the fourth quarter
and full twelve months of 2013, recent business developments, revenue
and net income guidance for full year 2014, and revenue guidance for the
first quarter of 2014. The conference call will be accessible by dialing 888/679-8035
or 617/213-4848 (international) and providing passcode 14085753.
A webcast of the conference call will be accessible from the company's
website at www.emergentbiosolutions.com,
Emergent BioSolutions is ofering call participants a pre-registration
option that expedites access to the call and minimizes hold times.
Pre-registrants will be issued a pin number to be used when dialing into
the live call which will provide quick access to the conference call by
bypassing the operator upon connection. Pre-registration, while not
mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PE7MCRMY6
A replay of the conference call will be accessible, approximately two
hours following the conclusion of the call, by dialing 888/286-8010 or
617/801-6888 and using the passcode 98777468. The replay will be
available through March 20, 2014. The webcast will be archived on the
company's website, www.emergentbiosolutions.com,
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to
protect and enhance life by offering specialized products to healthcare
providers and governments to address medical needs and emerging health
threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
[ Back To NFVZone's Homepage ]